Mammatumoren beim Hund – Teil 2: Ein Überblick über Diagnostik und Therapie

Mammatumore gehören zu den häufigsten Tumorerkrankungen der Hündin. Der 2. Teil des Beitrags gibt einen Überblick über weiterführende Diagnostik, Therapiemöglichkeiten und Prognose der Erkrankung in Abhängigkeit von Tumorhistologie und -stadium (Teil 1: kleintier.konkret 2017; 4: 10–16).

• Literatur

• 1 Arenas C, Pena L, Granados-Soler JL. et al. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study. Vet Rec 2016; 179 (5): 125
• 2 Cassali GD, Gobbi H, Malm C. et al. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours. Cytopathology 2007; 18 (3): 191-196
• 3 Chang SC, Chang CC, Chang TJ. et al. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998–2002). J Am Vet Med Assoc 2005; 227 (10): 1625-1629
• 4 Clemente M, Pérez-Alenza MD, Pena L. Metastasis of canine inflammatory versus non-inflammatory mammary tumours. J Comp Pathol 2010; 143 (2–3): 157-163
• 5 Clemente M, De Andrés PJ, Pena L. et al. Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy. Vet Rec 2009; 165 (3): 78-81
• 6 Mac Ewen EG, Harvey HJ, Patnaik AK. et al. Evaluation of effects of levamisole and surgery on canine mammary cancer. J Biol Response Mod 1985; 4 (4): 418-426
• 7 Karayannopoulou M, Kaldrymidou E, Constantinidis TC. et al. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J Comp Pathol 2005; 133 (4): 246-252
• 8 Karayannopoulou M, Kaldrymidou E, Constantinidis TC. et al. Adjuvant post-operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 2001; 48 (2): 85-96
• 9 Kristiansen VM, Pena L, Diez Córdova L. et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with mammary carcinomas: a randomized controlled trial. J Vet Intern Med 2016; 30 (1): 230-241
• 10 Kristiansen VM, Nodtvedt A, Breen AM. et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial. J Vet Intern Med 2013; 27 (4): 935-942
• 11 Kurzman ID, Gilbertson SR. Prognostic factors in canine mammary tumors. Semin Vet Med Surg (Small Anim) 1986; 1 (1): 25-32
• 12 Lavalle GE, De Campos CB, Bertagnolli AC. et al. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. In Vivo 2012; 26 (3): 375-379
• 13 Lurie DM, Seguin B, Schneider PD. et al. Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors. Invest Radiol 2006; 41 (4): 415-421
• 14 Marconato L, Romanelli G, Stefanello D. et al. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003–2008). J Am Vet Med Assoc 2009; 235 (8): 967-972
• 15 Marconato L, Lorenzo RM, Abramo F. et al. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. Vet Comp Oncol 2008; 6 (2): 90-101
• 16 Misdorp W, Hart AA. Prognostic factors in canine mammary cancer. J Natl Cancer Inst 1976; 56 (4): 779-786
• 17 Misdorp W, Herder BA den. Bone metastasis in mammary cancer. A report of 10 cases in the female dog and some comparison with human cases Br J Cancer 1966; 20 (3): 496-503
• 18 Morris JS, Dobson JM, Bostock DE. et al. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet Rec 1998; 142 (24): 656-658
• 19 De las Mulas JM, Millán Y, Dios R. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet Pathol 2005; 42 (2): 200-112
• 20 Nieto A, Pena L, Pérez-Alenza MD. et al. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 2000; 37 (3): 239-247
• 21 Pena L, De Andrés PJ, Clemente M. et al. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Vet Pathol 2013; 50 (1): 94-105
• 22 Pereira CT, Luiz Navarro MF, Williams J. et al. 99mTc-labeled dextran for mammary lymphoscintigraphy in dogs. Vet Radiol Ultrasound 2008; 49 (5): 487-491
• 23 Pereira CT, Rahal SC, de Carvalho Balieiro JC. et al. Lymphatic drainage on healthy and neoplasic mammary glands in female dogs: can it really be altered?. Anat Histol Embryol 2003; 32 (5): 282-290
• 24 Philibert JC, Snyder PW, Glickman N. et al. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 2003; 17 (1): 102-106
• 25 Queiroga FL, Perez-Alenza MD, Silvan G. et al. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer Res 2005; 25 (6B): 4269-4275
• 26 Rutteman GR. Mammatumoren. In: Kessler M. Hrsg. Kleintieronkologie. 2 Ausg. Stuttgart: Enke; 2005: 237-248
• 27 Rutteman GR, Withrow S, MacEwen E. Tumors of the mammary gland. In: Withrow SJ, Vail DM, Page RL. eds. Small Animal Clinical Oncology. 5^th ed. St. Louis: Elsevier Saunders; 2013
• 28 Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 1969; 43 (6): 1249-1261
• 29 Shofer FS, Sonnenschein EG, Goldschmidt MH. et al. Histopathologic and dietary prognostic factors for canine mammary carcinoma. Breast Cancer Res Treat 1989; 13 (1): 49-60
• 30 Simon D, Schoenrock D, Nolte I. et al. Cytologic examination of fine-needle aspirates from mammary gland tumors in the dog: diagnostic accuracy with comparison to histopathology and association with postoperative outcome. Vet Clin Pathol 2009; 38 (4): 521-528
• 31 Simon D, Schoenrock D, Baumgärtner W. et al. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. J Vet Intern Med 2006; 20 (5): 1184-1190
• 32 Sorenmo KU, Worley DR, Goldschmidt MH. Tumors of the mammary gland. In: Withrow SJ, Vail DM, Page RL. eds. Small Animal Clinical Oncology. 5^th ed. St. Louis: Elsevier Saunders; 2013: 538-556
• 33 Sorenmo KU, Kristiansen VM, Cofone MA. et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol 2009; 7 (3): 162-172
• 34 Sorenmo KU, Shofer FS, Goldschmidt MH. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med 2000; 14 (3): 266-270
• 35 de M Souza CH, Toledo-Piza E, Amorin R. et al. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can Vet J 2009; 50 (5): 506-510
• 36 Stratmann N, Failing K, Richter A. et al. Mammary tumor recurrence in bitches after regional mastectomy. Vet Surg 2008; 37 (1): 82-86
• 37 Tran CM, Moore AS, Frimberger AE. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol 2016; 14 (3): 252-262
• 38 Tuohy JL, Milgram J, Worley DR. et al. A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology. Vet Comp Oncol 2009; 7 (2): 81-91
• 39 Yamagami T, Kobayashi T, Takahashi K. et al. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J Vet Med Sci 1996; 58 (11): 1079-1083
• 40 Yamagami T, Kobayashi T, Takahashi K. et al. Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours. J Small Anim Pract 1996; 37 (10): 462-464